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Forensic caseworkAbstract Background: The passage of nucleated cells between mother and fetus is well recognized
(Lo et al., 1989, 1996). As well as, cell-free fetal DNA in maternal plasma or serum is at present
widely investigated as a source of fetal genetic material (Stanghellini et al., 2006) [18]. There has
been much recent interest in the use of DNA derived from plasma or serum (Boland, 1996). This
DNA can be utilized for molecular diagnosis as well as prenatal sex discernment.
Objective: To establish an easy, reliable, and completely safe method for fetal gender determina-
tion alternative to conventional exhausting current techniques applied in gynecologic hospitals and
clinics, besides its further applications in forensic casework.
Methods: EDTA-Blood samples were taken from 30 pregnant women all in the third trimester of
pregnancy, then plasma was separated from each sample, from which DNA was isolated using a
QIAamp DNAMini Kit, with special modiﬁcations done in the extracting procedure to concentrate
and obtain minute quantities of fetal DNA, together with maternal DNA, from maternal plasma. In
addition, bloodstain samples were taken from the husbands of women who were pregnant with male
fetuses from which DNA was isolated using a QIAamp DNA Micro Kit for comparison. DNA
quantiﬁcation was done using a Real-time PCR utilizing Quantiﬁler Duo Kit. PCR was done using
an AmpFlSTR Y-Filer Kit, then ampliﬁed products were typed using a 3130 Genetic Analyzer.
Results: Full and partial Y-STR proﬁles (6–17 STR loci) were obtained from all plasma samples
taken from pregnant women with male fetuses, while negative Y-STR proﬁles (no single STR locus)
were obtained from all plasma samples taken from pregnant women with female fetuses.
48 H.M.H. Aal-Hamdan et al.Conclusion: It is recommended to use Y-STR proﬁling as an alternative technique for fetal gender
determination during the third trimester of pregnancy, in addition to its signiﬁcance in forensic case-
work.
 2014 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.Table 1 Week of pregnancy and gender of fetus for all women
included in the study.
Sample identity Week of pregnancy Gender of fetus
ID 1 36 M
ID 2 31 M
ID 3 33 M
ID 4 30 M
ID 5 36 M
ID 6 38 M
ID 7 35 M
ID 8 32 M
ID 9 39 M
ID 10 34 M
ID 11 32 M
ID 12 33 M
ID 13 30 F
ID 14 31 F
ID 15 34 F
ID 16 34 F
ID 17 27 F
ID 18 28 F
ID 19 33 F
ID 20 27 F
ID 21 28 F
ID 22 33 F1. Introduction
Prenatal sex discernment is the prenatal testing for discerning
the sex of a fetus before birth. Prenatal sex discernment can be
performed via different technical methods. Chorionic villus
sampling (CVS) and amniocentesis are two rather invasive
testing procedures. The difﬁculty of these tests and the risk
of damage to the fetus, potentially result in miscarriage or con-
genital abnormalities. Obstetric ultrasonography, either trans-
vaginally or transabdominally, can check for the sagittal sign
as a marker of fetal sex. It gives a result in 90% of cases [1].
The accuracy of fetal sex discernment using obstetric ultraso-
nography depends on a number of factors including [2]:
1. Gestational age.
2. Precision of sonographic machine.
3. Expertise of the operator.
4. Fetal posture.
According to the 1982 World Health Organization and
U.S. Department of Health and Human Services report,
‘‘Effects of Ultrasound on Biological Systems’’, stated that ani-
mal studies suggest that neurological, behavioral, developmen-
tal, immunological, hematological changes and reduced fetal
weight can result from exposure to ultrasound. However,
studies have since refuted, challenged or discarded ﬁndings
that ultrasound may have a bearing on fetal birth weight or
speech development [3].
Noninvasive prenatal diagnosis constitutes a long-sought
goal in human genetics, where the passage of fetal nucleated
cells into maternal blood is a well-recognized phenomenon
[4–6], and it makes possible the use of these cells for noninva-
sive prenatal diagnosis [7,18]. Signiﬁcant advances have been
made in the enrichment and isolation of fetal cells for analysis
[8,9]. However, most techniques are time consuming, labor
intensive, or difﬁcult to implement on a large scale. These lim-
itations prompted for the investigation of alternative sources
of fetal genetic material for molecular analysis [10].
Our study aims to launch an alternative technique to be
applicable especially in the Middle East in all obstetric and
gynecologic hospitals, to determine the gender of the fetus with
a percent of accuracy reaching 100%, without subjecting
pregnant women to the disadvantages of conventional current
techniques. The work is carried out in accordance with The
Code of the World Medical Association (Declaration of
Helsinki) for experiments involving humans.
ID 23 37 F
ID 24 29 F
ID 25 29 F
ID 26 28 F
ID 27 30 F
ID 28 31 F
ID 29 29 F
ID 30 32 F2. Subjects and methods
Thirty peripheral blood samples were collected from 30 preg-
nant women aged from 20 to 35 years all in the third trimester
of pregnancy (mean gestational age, 31.96; range,
27–39 weeks), where blood was collected in EDTA tubes. Afterthe delivery of all women included in the study, it is indicated
that 18 of them had delivered a girl and the other 12 had deliv-
ered a boy (one of them delivered a twin of 2 boys) (Table 1).
According to the delivery results, 12 blood samples were col-
lected from the husbands of women who were pregnant with
male fetuses, in the form of bloodstain samples. All samples
were taken from Saudi families after informed consents had
been obtained from all women included in the study and
their husbands and consent of the ethics committee of our
university.
Six ml EDTA-Blood from each sample from a pregnant
woman was centrifuged at 3000g for 20 min, and 2 ml plasma
from each sample was carefully removed from collection tubes
and transferred into plain polypropylene tubes. The plasma
samples were then recentrifuged at 3000g for 10 min, and the
supernatants were collected in fresh tubes. Samples were stored
at 20 C until further processing. Few blood drops were
obtained from the thumb of each husband by using a sterile
lancet, and deposited on a Whatman ﬁlter paper. Bloodstains
were dried in air for half an hour, and put inside sterile plastic
Table 2 Human and male DNA concentrations in maternal
plasma samples for women pregnant with male fetuses.
Sample identity Human DNA
concentration (pg/ll)
Male DNA
concentration (pg/ll)
ID 1 100.0 17.9
ID 2 304.0 1120.0
ID 3 155.0 10.2
ID 4 19.5 11.6
ID 5 57.6 26.3
ID 6 1300.0 82.0
ID 7 283.0 31.2
ID 8 34.8 5.9
ID 9 44.9 21.3
ID 10 20.0 17.2
ID 11 49.2 6.9
ID 12 8.8 3.7
Table 3 Human and male DNA concentrations in maternal
plasma samples for women pregnant with female fetuses.
Sample identity Human DNA
concentration (pg/ll)
Male DNA
concentration (pg/ll)
ID 13 11.1 –
ID 14 34.0 18.1
ID 15 126.0 18.1
ID 16 69.0 –
ID 17 219.0 –
ID 18 145.0 50.1
ID 19 37.4 –
ID 20 181.0 –
ID 21 21.3 3.79
ID 22 44.0 –
ID 23 21.0 –
ID 24 10.4 –
ID 25 4.7 –
ID 26 103.0 –
ID 27 61.2 3.3
ID 28 3.3 –
ID 29 8.7 13.5
ID 30 2.1 –
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processing.
DNA (maternal and fetal) was extracted from separated
maternal plasma samples using a QIAamp DNA Mini kit
(Qiagen) with the ‘‘DNA Puriﬁcation from Blood or Body
Fluids (Spin Protocol)’’ [11]. We used 500 ll plasma sample
per column, and eluted the DNA (in the ﬁnal step) in 50 ll
of deionized water. After completing the extraction procedure,
the DNA eluate was concentrated by the use of a Concentrator
plus (Eppendorf) by putting the samples at V-AQ (vacuum-
aqueous) mode for 18 min, obtaining a ﬁnal volume of concen-
trated DNA equals 20 ll. Extracted DNA was stored at 4 C
for less than 2 weeks until further processing.
DNA was extracted from bloodstain samples using a QIA-
amp DNA Micro kit (Qiagen) with the ‘‘Isolation of Genomic
DNA from Dried Blood Spots’’ protocol [12]. Extracted DNA
was stored at 4 C for less than 2 weeks until further
processing.
Two microliters of each extracted sample was quantitated
utilizing a Quantiﬁler Duo kit (Life Technologies) according
to manufacturer’s protocol [13] using the Real-time PCR
7500 (Applied Biosystems).
The AmpFLSTR Yﬁler PCR Ampliﬁcation Kit was uti-
lized to amplify the following Y-STR loci: DYS19, DYS385a/
b, DYS389I, DYS389II, DYS390, DYS391, DYS392,
DYS393, DYS437, DYS438, DYS439, DYS448, DYS456,
DYS458, DYS635, and Y GATA H4 located on the Y-Chro-
mosome of male fetuses. Ampliﬁcations were conducted
according to manufacturer’s recommendations using a Gene-
Amp PCR System 9700 thermal cycler (Applied Biosystems).
AmpFLSTR Control DNA 9947A and 007 (Applied Biosys-
tems) were ampliﬁed. PCR ampliﬁcation was performed in a
ﬁnal volume of 25 ll containing PCR reaction mix 9.2 ll,
Taq Gold DNA Polymerase (5 U/ml) 0.8 ll, Y-Filer primer
set 5 ll, and extracted DNA template 10 ll. Initial incubation
at 95 C for 11 min was followed by denaturation (94 C for
1 min), annealing (61 C for 1 min) and extension (72 C for
1 min) for 29 cycles when processing plasma samples and for
28 cycles when processing bloodstain samples. At the end of
PCR there was incubation at 60 C for 80 min followed by a
ﬁnal hold at 4 C [14]. Ampliﬁed samples were stored at 4 C
for less than 2 weeks until further processing.
One microliter of PCR products of each sample was mixed
with 8.6 ll of Hi-Di formamide (Sigma–Aldrich, St. Louis,
MO, USA) and 0.4 ll of Genescan-500 LIZ size standard
(Applied Biosystems, Warrington, Great Britain). The mixture
was denatured at 95 C for 3 min and cooled to 4 C for 3 min.
Electrophoresis was performed on an ABI 3130 Genetic Ana-
lyzer by using POP4 polymer (Applied Biosystems, Fosters
City, CA, USA). Samples were injected for 5 s at 15 kV, and
then run at 15 kV for 25 min at a constant temperature of
60 C. The raw data were collected by the software (3130 Data
Collection, version 3.0) and analyzed by the software (GeneM-
apper ID-X Software, version 1.0). Genotypes were deter-
mined by comparing the size of the unknown fragments with
the allelic ladders provided by the manufacturer [14].
3. Results and discussion
Real-time PCR was done two times using a Quantiﬁler Duo
kit; in the ﬁrst time it was done for the DNA extracted frommaternal plasma samples from the 30 women included in the
study during pregnancy, and in the second time it was done
for the DNA extracted from the 12 bloodstain samples from
the husbands of the women who were pregnant with male
fetuses after delivery. Table 2 shows the concentrations of total
human DNA (maternal and fetal) and male DNA detected in
maternal plasma samples of women pregnant with male
fetuses. According to the results shown in Table 2; by compar-
ing the mean human DNA concentration (198 pg/ll), with the
mean male DNA concentration (21.29 pg/ll), we found that
the concentration of male DNA in maternal plasma of preg-
nant women with male fetuses reaches about 10.75% from
the concentration of human DNA, which indicates the pres-
ence of maternal DNA in the maternal plasma with a percent-
age approximately reaching 10-folds that of fetal DNA.
Taking into consideration ignoring the sample ‘‘ID 2’’ in the
calculation of the mean male DNA concentration, because it
possesses a very high male DNA concentration (1120 pg/ll)
compared with the rest of the samples, may be because that
Figure 1 Electropherogram showing a maternal plasma sample for a woman pregnant with a female fetus.
Table 4 Male DNA concentrations in bloodstain samples
from husbands.
Sample identity Male DNA
concentration (ng/ll)
ID 31 8.5
ID 32 4.7
ID 33 12.36
ID 34 4.75
ID 35 9.21
ID 36 4.72
ID 37 4.77
ID 38 4.62
ID 39 11.5
ID 40 9.94
ID 41 8.22
ID 42 4.26
50 H.M.H. Aal-Hamdan et al.woman was pregnant in a twin of 2 males and delivered 2 boys.
Also, it is quite obvious from the results shown in Table 2 that
Y-Filer kit can be used successfully to amplify male DNA with
concentrations as low as 3.7 pg/ll.
Table 3 shows the concentrations of total human DNA
(maternal and fetal) and male DNA detected in maternal
plasma samples of women pregnant with female fetuses.
According to the results shown in Table 3, it is clear that the
male DNA concentration in maternal plasma of 12 out of 18
samples equals zero, this is logically because there is no male
fetuses inside the uterus of any of those women. The rest of
samples (6 out of 18) contains minute quantities of male
DNA range from 3.3 pg/ll to 50.1 pg/ll. It was found from
the clinical history reports of those 6 women, that only those
6 women have had a previous pregnancy with male fetuses in
the past, where 5 of them delivered a boy and 1 had an abor-
tion and did not complete pregnancy. It is proven scientiﬁcally
that women who were pregnant with male fetus in the past
whether the pregnancy completed and delivery occurred or
the pregnancy did not complete remain possessing minute
quantities of male DNA in their maternal circulation which
may persists for decades [15]. Despite the presence of these
detected minute quantities of male DNA in the 6 maternal
plasma samples, these minute concentrations of male DNA
did not have any effect on the Y-STR typing of these samples
and all had given a negative result in all Y-STR loci, indicating
that the gender of the fetus is female (Fig 1).
Table 4 shows the male DNA concentrations detected in
bloodstain samples from the husbands of women pregnant
with male fetuses. According to the results shown in Table 4,it is clear that the mean male DNA concentration (7.295 ng/
ll), when compared to the mean male DNA concentration in
maternal plasma samples of pregnant women with male fetuses
(21.29 pg/ll), shows a huge difference which reﬂects the varia-
tion between the concentration of male fetal DNA present in
maternal circulation and the concentration of male DNA in
adult male circulation, where this difference may exceed
300-folds. This fact conﬁrms the meagerness of fetal DNA
molecules present in maternal circulation, which necessitates
the performance of the concentration step which was done at
the end of the extraction procedure to get the most beneﬁt with
DNA molecules in maternal plasma.
Table 5 Y-STR typing of maternal plasma samples for women pregnant within male fetuses. (ND: not detected).
ID 1 ID 2 ID 3 ID 4 ID 5 ID 6 ID 7 ID 8 ID 9 ID 10 ID 11 ID 12
DYS456 14 15 14 14 15 14 14 14 15 14 14 14
DYS389I 13 13 13 14 13 13 13 13 13 13 13 13
DYS390 23 23 23 ND 23 23 23 23 24 23 22 23
DYS389II 30 29 ND ND 30 ND 30 30 29 29 ND 30
DYS458 18 17 19 ND 19 17 18 18 17 18 18 18
DYS19 14 14 14 ND 14 14 14 14 15 14 14 14
DYS385a/b 14, ND 13, ND 13, ND ND 13, 15 13, 13 12, ND 12, 19 18, 19 13, 18 ND 14, 17
DYS393 12 12 12 12 12 12 12 12 12 12 12 12
DYS391 11 10 10 11 11 11 11 11 10 10 11 12
DYS439 11 12 11 ND 11 11 12 11 14 11 11 11
DYS635 21 20 ND ND 21 ND 21 ND 21 21 21 22
DYS392 11 11 ND ND ND ND 11 ND 11 11 ND ND
Y GATA H4 11 11 12 11 11 11 11 11 13 11 11 11
DYS437 14 14 13 ND 14 14 14 14 14 14 14 14
DYS438 10 10 10 10 10 10 10 10 10 10 10 10
DYS448 ND 19 ND ND ND 20 20 ND 19 20 20 19
Figure 2 Sizes of ampliﬁed Y-STRs included in the Y-Filer system [16].
Table 6 Number and percentage of maternal plasma samples
from pregnant women with male fetuses detected in each
Y-STR Locus.
Y-STR Loci Number of
samples detected
Percentage of
samples detected (%)
DYS456 12/12 100
DYS389I 12/12 100
DYS390 11/12 91.6
DYS389II 8/12 66.6
DYS458 11/12 91.6
DYS19 11/12 91.6
DYS385a 10/12 83.3
DYS385b 6/12 50
DYS393 12/12 100
DYS391 12/12 100
DYS439 11/12 91.6
DYS635 8/12 66.6
DYS392 5/12 41.6
Y GATA H4 12/12 100
DYS437 11/12 91.6
DYS438 12/12 100
DYS448 7/12 58.3
Mean 171/204 83.8
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used to analyze maternal plasma samples collected from
women during the third trimester of pregnancy, revealed the
presence of male fetal DNA expressed in a varied number of
Y-STR loci in all women who delivered a boy afterward.
The accuracy of multiplex PCR assay to detect male fetal
DNA was 100%. At the same time, negative results were
obtained in all cases who delivered a girl afterward showing
no allele peaks at any of the analyzed Y-STR loci. All blood-
stain samples from husbands show complete Y-STR proﬁles.
Table 5 shows the results of Y-STR typing of maternal
plasma samples for women pregnant with male fetuses. From
the results shown in Table 5, we notice that some plasma sam-
ples get full DNA proﬁles while others get partial DNA proﬁles
due to the absence of some alleles in some Y-STR loci in their
typing. In order to summarize the results of DNA typing shown
in Table 5 with respect to each Y-STR locus included in the Y-
Filer kit (Fig. 2), the number and percentage ofmaternal plasma
samples detected in each Y-STR locus are listed in Table 6.
According to the results shown in Table 6, we notice that the
6 Y-STR loci: DYS456, DYS389I, DYS393, DYS391, Y
GATA H4, and DYS438 are detected in all maternal plasma
samples with a percentage of detection reaching 100%, the 5
Y-STR loci: DYS390, DYS458, DYS19, DYS439, and
DYS437 are detected in 11 out of 12 samples with a percentage
→ Husband
→ Male Fetus
→ Husband
→ Male Fetus
→ Husband
→ Male Fetus
→ Husband
→ Male Fetus
(a)
(b)
Figure 3 (a) Electropherogram showing a comparison between a maternal plasma sample for a woman pregnant with a male fetus and a
husband sample. (b) Electropherogram showing a comparison between a maternal plasma sample for a woman pregnant with a male fetus
and a husband sample (continued).
52 H.M.H. Aal-Hamdan et al.of detection reaching 91.6%, the 3 Y-STR loci: DYS389II,
DYS635, and DYS385a are detected in 8, 8, and 10 samples
respectively with a percentage of detection ranging from
66.6% to 83.3%, and the 3 Y-STR loci: DYS392, DYS385b,
and DYS448 are detected in 5, 6, and 7 samples respectively
with a percentage of detection ranging from 41.6% to 58.3%.
From the previous analysis, we notice that; as the size of the
Y-STR locus is increased (Fig. 3), the chance of its detection in
maternal plasma is decreased. There are 5 out of 6 Y-STR loci
detected in all maternal plasma samples, their sizes are lessthan 200 base pairs, and the sixth locus is less than 275 base
pairs. The 5 Y-STR loci detected in 11 out of 12 maternal
plasma samples have their sizes less than 250 base pairs. The
3 Y-STR loci (DYS389II, DYS635, and DYS385a) detected
in 8, 8, and 10 plasma samples have their sizes fall in the region
between 250 and 315 bp. And the 3 Y-STR loci (DYS392,
DYS385b, and DYS448) detected in 5, 6, and 7 plasma sam-
ples have their sizes fall in the region between 275 and 350 bp.
On the other side, Fig. 3 shows a comparison between a
Y-STR proﬁle for a bloodstain sample from a husband and
Fetal gender determination through Y-STR analysis of maternal plasma 53a Y-STR proﬁle for a maternal plasma sample from the wife.
In the ﬁgure, there is a complete concordance between the
alleles in the fetal male DNA proﬁle and the alleles in the hus-
band’s DNA proﬁle in all Y-STR loci, which means that the
male fetus of the wife possesses the same Y-STR typing as
the husband, i.e.: the male fetus is attributed to the males of
the family of the husband. In the same ﬁgure, we observe the
differences between the rfu values between both samples in
each Y-STR locus, determining a lower male DNA concentra-
tion in case of the maternal plasma sample compared with the
high DNA concentration of male DNA in the bloodstain sam-
ple of the husband.
4. Conclusions
The success in detecting the number of Y-STRs in the result of
Y-STR proﬁling analysis of maternal plasma of pregnant
women, means that the gender of the fetus is male, and at
the same time the negative result in the Y-STR proﬁling anal-
ysis in all Y-STR loci, means that the gender of the fetus is
female. Therefore; the results of the study prove the feasibility
of applying Y-STR typing as a gender determining test for the
detection of the gender of the fetus during the third trimester
of pregnancy with a percentage of accuracy reaching 100%.
Moreover, Y-STR proﬁling analysis can be done during
pregnancy to decide whether the male fetus is attributed to
the family of the alleged father or not. This can be achieved,
in case of denying, in all paternity cases where there is a differ-
ence between the Y-STR typing of the fetus and that of the
husband even in one Y-STR locus, and in case of proving, in
all paternity cases where the number of detected Y-STR loci
is greater than 8 [17].
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